In a 23-year-old woman presenting with an acute manic episode and normal labs, which mood stabilizer should be initiated first in addition to an antipsychotic?

Initial Treatment for Acute Mania in a Young Adult

For this 23-year-old woman presenting with acute mania, lithium should be initiated as the mood stabilizer in addition to the antipsychotic, as it is the only FDA-approved mood stabilizer for patients age 12 and older and has demonstrated efficacy for both acute mania and maintenance therapy. 1

Rationale for Lithium as First-Line Mood Stabilizer

Lithium holds unique regulatory status as the only agent with FDA approval specifically for bipolar disorder in young adults (approved down to age 12 years for acute mania and maintenance therapy). 1 This regulatory distinction is clinically meaningful given the patient's age of 23 years.

Evidence Supporting Lithium

• Multiple double-blind, placebo-controlled studies support lithium's efficacy in acute mania, though limited by small sample sizes and diagnostic variability 1
• Lithium has demonstrated benefit for comorbid substance abuse, which may be relevant given the need to rule out substance-induced mania 1
• Lower relapse rates were reported when antipsychotic medication was maintained for at least 4 weeks in combination with lithium for adolescents with acute psychotic mania 1

Alternative: Valproate

Valproate represents a reasonable alternative, particularly if rapid control is needed, as it showed a 53% response rate compared to lithium's 38% response rate in one comparative study of young patients with mania and mixed episodes. 1 However, valproate lacks FDA approval for this age group and requires careful monitoring for polycystic ovary disease in young women. 1

Combination Therapy Considerations

The combination of a mood stabilizer plus antipsychotic is more effective than either monotherapy, with network meta-analyses showing combination therapy has 96.1% probability of being the best treatment based on mania rating scale changes and 99.3% probability for responder rates. 2

When to Use Combination from the Start

• Severe presentations (as in this case with high-speed chase, marked agitation, and impulsive spending) warrant consideration of combination therapy as first-line treatment 3, 4
• Combination therapy shows efficacy advantages with standardized mean differences of -0.26 at 3 weeks and significant improvement observable within the first week (SMD -0.17) 4, 5
• The combination does not significantly increase dropout rates compared to monotherapy (RR 0.99,95% CI 0.88-1.12) 4

Critical Monitoring Requirements

Before initiating lithium, obtain baseline laboratory assessment including: 1

• Complete blood cell counts
• Thyroid function tests
• Urinalysis
• Blood urea nitrogen, creatinine, and serum calcium levels
• Pregnancy test (essential in this 23-year-old woman)

Once stable lithium dose is achieved, monitor lithium levels, renal and thyroid function, and urinalyses every 3-6 months. 1

Common Pitfalls to Avoid

• Do not use antidepressants - they must be stopped during manic episodes as they may destabilize mood or precipitate further mania 1, 3
• Avoid benzodiazepines in younger patients - while used for acute agitation in adults, they may cause disinhibition in younger individuals 1
• Do not discontinue treatment prematurely - the regimen needed to stabilize acute mania should be maintained for 12 to 24 months, as median time to relapse after switching to monotherapy is approximately 3 months 1
• Monitor for metabolic syndrome - given the antipsychotic component, baseline and ongoing monitoring of weight, blood pressure, fasting glucose, and lipid panel is essential 1

Treatment Duration

Maintain the acute stabilization regimen for 12-24 months minimum, as high relapse rates occur with premature discontinuation or switching to monotherapy. 1 Some individuals may require lifelong therapy when benefits outweigh risks. 1